Pain and opioid risk assessment featuring SOAPP® & COMM® to be available through Allscripts Developer Program
WALTHAM, Mass., July 2, 2018 — Inflexxion, Inc. announced today that its pain and opioid risk assessment software, PainCAS, is being featured as the Allscripts Developer Program (ADP) July app of the month. PainCAS enables Allscripts ambulatory EHR users to assess pain, functioning, and risk of problematic opioid-related behaviors in patients with chronic pain.
Allscripts Touchworks® EHR and Professional EHR™ users are invited to attend a webinar on Wednesday, July 25, at 1pm EST, to learn how implementing PainCAS can help your practice to:
- Standardize the assessment of pain, functioning, and risk with evidenced-based problematic opioid-related behavior risk assessments.
- Advance clinical outcomes by identifying changes in patient risk status over time, tracking patients’ pain profile in the context of ongoing treatment, and monitoring changes in patient functioning over time.
- Improve workflow by eliminating the need for paper assessments and reduce staff burden. Opioid risk is scored and interpreted automatically.
PainCAS is the only clinical tool of its kind to continually assess benefits and risks associated with opioid therapy throughout the entire patient journey. PainCAS increases patient engagement by providing individualized provider and patient reports, improves treatment outcomes by facilitating active measurement of function, and improves patient safety through validated, real-time risk assessments.
Inflexxion helps healthcare organizations, provider communities, pharmaceutical companies, and regulatory authorities to improve patient care and inform public policy. Through their strategic approach and depth of expertise, Inflexxion analyzes and disseminates health-related data for surveillance, risk management, epidemiological studies, quality improvement, and outcome measurement. Inflexxion’s unique data collection includes multiple data streams at the point-of-care, Internet Monitoring technology, and web-surveys with hard to reach populations. For more information visit www.inflexxion.com.
Contact: Christi Perkins, Inflexxion Inc., 617 614 0409, email@example.com